Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-12 Sale |
2025-03-14 5:59 pm |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
12,888 | $12.99 | $167,465 | 32,183 (Direct) |
View |
| 2025-03-03 Sale |
2025-03-04 8:18 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
12,846 | $42.1 | $540,817 | 75,287 (Direct) |
View |
| 2025-02-27 Sale |
2025-03-03 1:58 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
2,990 | $42.88 | $128,224 | 95,764 (Direct) |
View |
| 2024-06-12 Sale |
2024-06-12 7:47 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
9,806 | $45 | $441,270 | 57,981 (Direct) |
View |
| 2024-03-01 Sale |
2024-03-05 8:22 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
3,756 | $53.76 | $201,923 | 98,740 (Direct) |
View |
| 2024-01-30 Sale |
2024-02-02 4:57 pm |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
11,931 | $13.14 | $156,733 | 31,243 (Direct) |
View |
| 2023-05-04 Sale |
2023-05-05 2:16 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
4,378 | $45 | $197,010 | 51,982 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 7:59 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
3,161 | $45.25 | $143,035 | 95,539 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-08 12:25 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
5,140 | $62.95 | $323,563 | 34,438 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:08 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
2,886 | $66.62 | $192,265 | 64,478 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:46 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
310 | $81.14 | $25,153 | 28,358 (Direct) |
View |
| 2021-09-08 Sale |
2021-09-09 6:22 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
7,336 | $100.65 | $738,368 | 46,332 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-11 9:08 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
1,329 | $100 | $132,900 | 28,668 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-10 6:13 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
313 | $113.67 | $35,579 | 29,997 (Direct) |
View |
| 2021-03-01 Sale |
2021-03-03 8:47 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
3,970 | $138.17 | $548,535 | 41,227 (Direct) |
View |
| 2020-10-30 Sale |
2020-11-02 5:05 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
9,903 | $100.12 | $991,488 | 49,061 (Direct) |
View |
| 2020-10-28 Sale |
2020-10-30 5:28 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
97 | $100 | $9,700 | 58,871 (Direct) |
View |
| 2020-10-14 Sale |
2020-10-16 7:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
325 | $88 | $28,600 | 23,968 (Direct) |
View |
| 2020-10-08 Sale |
2020-10-13 5:53 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $95 | $950,000 | 59,293 (Direct) |
View |
| 2020-10-06 Sale |
2020-10-07 2:57 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $90 | $900,000 | 41,293 (Direct) |
View |
| 2020-09-23 Sale |
2020-09-24 4:47 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $85 | $850,000 | 51,293 (Direct) |
View |
| 2020-08-17 Sale |
2020-08-19 2:12 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
12,370 | $88.43 | $1,093,884 | 69,293 (Direct) |
View |
| 2020-05-18 Sale |
2020-05-19 7:12 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
2,722 | $74.72 | $203,374 | 27,312 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Option Award |
2025-03-11 6:53 pm |
N/A 2035-03-07 |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
18,510 | $0 | 56,217 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-04 8:18 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
18,443 | $0 | 75,287 (Direct) |
View |
| 2025-03-01 Option Award |
2025-03-03 1:58 pm |
N/A 2035-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
40,568 | $0 | 95,764 (Direct) |
View |
| 2024-10-18 Option Award |
2024-10-21 8:39 pm |
2025-05-31 2034-10-17 |
Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 8:22 pm |
N/A 2034-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
50,157 | $0 | 98,740 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 6:37 pm |
N/A 2034-02-07 |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
15,841 | $0 | 47,084 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-12 8:24 pm |
2024-06-09 2033-06-08 |
Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director |
29,532 | $0 | 29,532 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 7:59 pm |
N/A 2033-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
64,063 | $0 | 95,539 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 8:41 pm |
N/A 2033-01-27 |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
20,082 | $0 | 54,963 (Direct) |
View |
| 2022-04-21 Option Award |
2022-10-03 7:56 pm |
N/A 2027-02-28 |
Anebulo Pharmaceuticals Inc. | ANEB | Parschauer Karah Herdman Director |
30,425 | $0 | 30,425 (Direct) |
View |
| 2022-09-08 Option Award |
2022-09-09 7:25 pm |
2023-09-08 2032-09-07 |
Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:08 pm |
N/A 2032-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer |
38,900 | $0 | 64,478 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 9:01 pm |
N/A 2032-01-24 |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
38,295 | $0 | 57,608 (Direct) |
View |
| 2021-12-22 Option Award |
2021-12-23 5:58 pm |
N/A 2031-12-22 |
Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director |
19,495 | $0 | 19,495 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-09 6:22 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
7,336 | $54.5 | 46,332 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-09 6:22 pm |
N/A 2026-06-20 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
7,336 | $0 | 46,332 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 6:33 pm |
N/A 2031-06-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Parschauer Karah Herdman Director |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2021-05-06 8:47 pm |
N/A N/A |
Anebulo Pharmaceuticals Inc. | ANEB | Parschauer Karah Herdman Director |
0 | $0 | 82,290 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 8:47 pm |
N/A 2031-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
21,136 | $0 | 41,227 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 5:12 pm |
N/A N/A |
Evolus Inc. | EOLS | Parschauer Karah Herdman Director |
19,313 | $0 | 19,313 (Direct) |
View |
| 2020-10-30 Exercise |
2020-11-02 5:05 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
9,903 | $54.5 | 49,061 (Direct) |
View |
| 2020-10-30 Exercise |
2020-11-02 5:05 pm |
N/A 2026-06-20 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
9,903 | $0 | 49,061 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-30 5:28 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
97 | $54.5 | 58,871 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-30 5:28 pm |
N/A 2026-06-20 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
97 | $0 | 58,871 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-13 5:53 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $54.5 | 59,293 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-13 5:53 pm |
N/A 2026-06-20 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $0 | 59,293 (Direct) |
View |
| 2020-10-06 Exercise |
2020-10-07 2:57 pm |
N/A 2028-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $0 | 41,293 (Direct) |
View |
| 2020-10-06 Exercise |
2020-10-07 2:57 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $48.43 | 41,293 (Direct) |
View |
| 2020-09-23 Exercise |
2020-09-24 4:47 pm |
N/A 2028-03-01 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $0 | 51,293 (Direct) |
View |
| 2020-09-23 Exercise |
2020-09-24 4:47 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $48.43 | 51,293 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-19 2:12 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $54.5 | 69,293 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-19 2:12 pm |
N/A 2026-06-20 |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
10,000 | $0 | 69,293 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 8:02 pm |
N/A 2030-06-21 |
Arcturus Therapeutics Holdings Inc. | ARCT | Parschauer Karah Herdman Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-20 Tax Withholding |
2020-06-22 1:46 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
649 | $78.22 | 26,663 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 8:02 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
248 | $66.26 | 29,904 (Direct) |
View |